Written and maintained by CASRAI Editorial Board
Last updated
General reference information for lab and clinic staff; it is not medical advice and does not describe any clinical procedure.
Short answer
Radiopaque describes a material that blocks or absorbs X-rays, so it shows up on an X-ray or CT image instead of letting the beam pass through. Devices are made radiopaque on purpose, usually by adding a dense filler such as barium sulfate to the plastic, so staff can see them on imaging.
Definition and scope
The NCI Thesaurus defines radiodensity as “the transparency of a material to the passage of X-rays and other forms of radiation.” Radiopaque is the high end of that range: the less transparent a material is to X-rays, the more radiopaque it is. Its opposite, radiolucent, describes a material that X-rays pass through easily. Both words describe how a material behaves under X-ray based imaging; neither says anything about whether the material is safe, sterile or suitable for a given use.
Radiopaque definition
A radiopaque material is one that attenuates X-rays strongly enough to be distinguished from surrounding tissue or material on an image. This is an editorial reading of the radiodensity definition above, not a quotation.
Radiopaque meaning medical
In medicine the term covers two groups of products. One is implanted or inserted devices whose polymer is made visible on imaging. The other is contrast agents: the National Library of Medicine’s MeSH vocabulary describes contrast media as “substances used to allow enhanced visualization of tissues” and lists “Radiopaque Media” as an entry term for the heading.
How radiopacity is built into a product
Radiopacity can be designed into a product. Two approaches are described in the published literature: mixing a radiopaque filler into the polymer, and chemically attaching a radiopaque group to the polymer itself. The NCI Thesaurus entry for radiopaque embolic beads describes the second approach: hydrogel beads made from polyvinyl alcohol that “contain a covalently bound radiopaque moiety.”
Radiopaque materials: examples with sources
| Material or approach | What the source reports | Source |
|---|---|---|
| Barium sulfate in polyurethane | A catheter material study used thermoplastic polyurethane filled with barium sulfate (TPU/BaSO4) and reported that adding magnesium oxide preserved the “radiopacity of TPU/BaSO4 matrix.” | Padrao et al., Biomater Adv 2026 |
| Gadolinium nanoparticles in a resorbable polymer | Resorbable PPDO filters “cannot be easily visualized on conventional imaging such as CT or X-ray”; adding gadolinium nanoparticles raised measured radiopacity to 2713 +/- 105 HU (PPDO-Gd) in micro-CT, in a preclinical study. | Polymers (Basel) 2025 |
| Covalently bound radiopaque group | Radiopaque embolic beads built from polyvinyl alcohol with a bound radiopaque moiety. | NCI Thesaurus C227972 |
| Iodine contrast versus barium in a test model | In experimental swine blood clots, 65% iohexol gave initially higher radiopacity than barium, but opacity “rapidly decreased with saline soaking”; the authors concluded iodine-based contrast “does not offer any advantage” over barium for opacifying the clots. | Luo et al., Radiol Oncol 2013 |
These are research and reference-vocabulary findings, not product claims; a specific product’s radiopacity is stated in its own instructions for use.
Where it matters for labs, clinics and supply decisions
Radiopacity is a property that can be missing or can change, which is why it is worth checking in product documentation rather than assuming:
- It can be absent. The resorbable filters in the 2025 study were hard to see on conventional imaging until a radiopaque additive was included.
- It can fade. In the same study radiopacity “decreased gradually over 10-12 weeks,” and in the clot model iodine-based opacity dropped after soaking in saline.
- Different materials behave differently. The examples above show filler-based, additive-based and chemically bound approaches, each reported under its own test conditions.
For tubes, drains and ports, staff reading product literature can look for how the manufacturer states visibility on imaging. CASRAI guides on devices that are made radiopaque include the central venous catheter guide, the chest tube guide, the Blake drain guide, the Groshong catheter guide and the drainage catheter stocking guide.
Common misunderstandings
- Radiopaque is not the same as a contrast agent. Contrast media are substances given to make tissues visible; a radiopaque device material is part of the product itself.
- Radiopaque is not a quality grade. It describes X-ray behavior only.
- Radiopacity is not permanent by default. Published studies report it fading in specific materials and test conditions.
- Barium is not the only option. Iodine compounds, gadolinium and chemically bound groups are all reported.
FAQ
What does radiopaque mean?
It means a material blocks X-rays and appears on an X-ray or CT image, rather than letting the beam pass through.
What is the radiopaque definition?
A radiopaque material is one with low transparency to X-rays, the high end of the radiodensity range defined by the NCI Thesaurus.
What are radiopaque materials?
Examples reported in the literature are barium sulfate fillers in polyurethane, gadolinium nanoparticles in a resorbable polymer, covalently bound radiopaque groups in hydrogel beads, and iodine-based contrast such as iohexol.
What does radiopaque mean in medical terms?
It describes devices or substances that are visible on X-ray based imaging, including contrast media, which MeSH lists under the entry term “Radiopaque Media.”
Sources
All links checked 2026-10-30.
- NCI Thesaurus, “Radiodensity” (C96627): https://api-evsrest.nci.nih.gov/api/v1/concept/ncit/C96627
- NCI Thesaurus, “Radiopaque Embolic Bead” (C227972): https://api-evsrest.nci.nih.gov/api/v1/concept/ncit/C227972
- National Library of Medicine, MeSH D003287 “Contrast Media”: https://id.nlm.nih.gov/mesh/D003287.html
- Padrao et al., Biomater Adv 2026;191:215207, doi 10.1016/j.bioadv.2026.215207: https://pubmed.ncbi.nlm.nih.gov/42837752/
- Luo et al., Radiol Oncol 2013;47(1):14-8, doi 10.2478/raon-2013-0001: https://pmc.ncbi.nlm.nih.gov/articles/PMC3573829/
- Resorbable PPDO filter study, Polymers (Basel) 2025, doi 10.3390/polym17060716: https://pmc.ncbi.nlm.nih.gov/articles/PMC11945502/
